TerminatedPhase 1NCT01479023

Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid Tumors

Studying Soft tissue sarcoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Washington University School of Medicine
Principal Investigator
A. Craig Lockhart, M.D.
Washington University School of Medicine
Intervention
64Cu-DOTA-U3-1287(drug)
Enrollment
12 target
Eligibility
18 years · All sexes
Timeline
20122013

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01479023 on ClinicalTrials.gov

Other trials for Soft tissue sarcoma

Additional recruiting or active studies for the same condition.

See all trials for Soft tissue sarcoma

← Back to all trials